4.7 Review

Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment

Journal

INTERNATIONAL JOURNAL OF CANCER
Volume 143, Issue 12, Pages 3050-3060

Publisher

WILEY
DOI: 10.1002/ijc.31717

Keywords

immunotherapy; immune checkpoint inhibitor; nanoparticle; photothermal therapy; photodynamic therapy; tumor

Categories

Funding

  1. China Postdoctoral Science Foundation [2016M590505, 2017T100407]
  2. Jiangsu Provincial Medical Talent Foundation
  3. National Natural Science Foundation of China [81572976, 81872493, 81803151]
  4. Postgraduate Research AMP
  5. Practice Innovation Program of Jiangsu Province [KYCX17_1715, KYCX17_1718]

Ask authors/readers for more resources

Nanoparticle-based phototherapies, such as photothermal therapy (PTT) and photodynamic therapy (PDT), exhibit strong efficacy, minimal invasion and negligible side effects in tumor treatment. These phototherapies have received considerable attention and been extensively studied in recent years. In addition to directly killing tumor cells through heat and reactive oxygen species, PTT and PDT can also induce various antitumor effects. In particular, the resultant massive tumor cell death after PTT and PDT triggers immune responses, including the redistribution and activation of immune effector cells, the expression and secretion of cytokines and the transformation of memory T lymphocytes. The antitumor effects can be enhanced by immune checkpoint blockage therapy. This article reviewed the recent advances of nanoparticle-based PTT and PDT, summarized the studies on nanoparticle-based photothermal and photodynamic immunotherapies in vitro and in vivo, and discussed challenges and future research directions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available